ABSTRACT. Hoffman, J.R., J.R. Stout, M.J. Falvo, J. Kang, and N.A. Ratamess. Effect of low-dose, short-duration creatine supplementation on anaerobic exercise performance. J. Strength Cond. Res. 19(2):260-264. 2005.-To examine the efficacy of a low-dose, short-duration creatine monohydrate supplement, 40 physically active men were randomly assigned to either a placebo or creatine supplementation group (6 g of creatine monohydrate per day). Testing occurred before and at the end of 6 days of supplementation. During each testing session, subjects performed three 15-second Wingate anaerobic power tests. No significant (p Ͼ 0.05) group or time differences were observed in body mass, peak power, mean power, or total work. In addition, no significant (p Ͼ 0.05) differences were observed in peak power, mean power, or total work. However, the change in the rate of fatigue of total work was significantly (p Ͻ 0.05) lower in the creatine supplementation group than in the placebo group, indicating a reduced fatigue rate in subjects supplementing with creatine compared with the placebo. Although the results of this study demonstrated reduced fatigue rates in patients during high-intensity sprint intervals, further research is necessary in examining the efficacy of low-dose, short-term creatine supplementation.
INTRODUCTION

S
cientific studies have consistently demonstrated the efficacy of creatine supplementation for increasing muscular strength and body mass (1, 2, 8, 10, 13, 14, 18, 23, 26, 29, 30) as well as increasing the synthesis of muscle contractile proteins (29, 31) . The majority of these studies have used a normal dosing regimen for the duration of their investigations. A typical creatine supplementation regimen involves a ''loading phase'' of 20 g·d Ϫ1 (0.3 g·kg Ϫ1 ) for 5 days to maximize muscle creatine stores, followed by a maintenance phase of 2 g·d Ϫ1 (0.03 g·kg Ϫ1 ) (11, 12, 13, 30) . However, similar muscle creatine concentrations can be achieved without using a loading phase by ingesting 3 g·d Ϫ1 for 30 days (12) . The only difference between these 2 dosing schemes is in the length of time needed to achieve maximal muscle creatine concentrations (30 days vs. 5 days).
Most reports of creatine supplementation have been quite favorable concerning side effects and potential health risks (15, 19, 21) . Anecdotal reports of gastrointestinal discomfort, dehydration, and muscle cramping have been associated with the loading phase (27) . Controlled studies, however, have failed to support this observation (9, 13, 26, 29) . Nevertheless, some athletes may still avoid a loading phase when beginning a creatine supplementation program. Although this supplementation regimen does not reduce the long-term effectiveness of creatine, the ability to provide any ergogenic benefit during short-term supplementation is not well understood. Most studies demonstrating the efficacy of short-term (5-6 days) creatine supplementation have used a loading dose (20 g·d
Ϫ1
) as their supplement regime (4, 5, 17, 20, 24) . There is only one investigation known that has shown there to be ergogenic benefits of a low-dose creatine supplementation (3) . However, in that study, a dosing scheme of 7.7 g·d Ϫ1 (0.1 g·kg Ϫ1 ) dose was used during 28 days of supplementation. Although this was a much longer supplementation period than typically seen during short-term studies, it is the first study to show efficacy with a low-dose, relatively short duration supplement regimen. The purpose of this study was to examine the efficacy of a low-dose (6 g·d Ϫ1 ), short-duration (6 days) supplementation regimen on repetitive, high-intensity anaerobic exercise in active, college-aged men.
METHODS
Experimental Approach to the Problem
The experimental design was double blind and involved 40 physically active college-aged men. Subjects were randomly assigned to a supplement or a placebo group. The supplement group consumed 6 g of creatine (0.1 g·kg Ϫ1 ), whereas the control group was given a placebo similar in appearance and taste. Anaerobic exercise performance measures were conducted before and immediately following 6 days of supplementation. All testing sessions were conducted at the same time of day.
Subjects
Forty physically active men volunteered as subjects for this investigation. Following an explanation of all procedures, risks, and benefits, each subject gave his informed consent to participate in this study. The Institutional Review Board of the college approved the research protocol. All subjects were free of any musculoskeletal and neuroendocrine disorders. In addition, all subjects reported being free of any anabolic supplements or drugs during the previous year and refrained from creatine supplementation for at least 6 weeks before the start of this study. The subjects also refrained from any additional nutritional supplementation during this study. Dietary intake was not monitored, and fluid intake was not measured, but subjects were encouraged to adhere to their normal dietary patterns and to consume between 8 and 10 glasses of water per day. In addition, subjects were asked to refrain from the use of caffeine from 24 hours before the study until the end of the study.
Experimental Design
Subjects reported to the human performance laboratory on 3 separate occasions. During the first session, subjects were familiarized with the exercise testing procedure (three 15-second Wingate anaerobic power tests). The additional 2 sessions were the experimental exercise testing sessions. There was a minimum of 24 hours between the familiarization session and the first experimental session, and 6 days separated the 2 experimental testing sessions (T1 and T2). Following the familiarization session subjects were randomly assigned to either a placebo ( 
Performance Measures
To quantify anaerobic power performance, all subjects performed the Wingate anaerobic power test (Lode Excalibur, Groningen, The Netherlands). After a warm-up period of 5 minutes pedaling at 60 rpm, interspersed with 4 all-out sprints lasting 5 seconds, the subjects pedaled for 15 seconds at maximal speed against a constant force. The subjects then performed an active recovery (i.e., pedaling at 60 rpm unloaded) for 1 minute and proceeded to perform an additional 15-second sprint. This process was repeated for a third time. A total of three 15-second sprints were performed. The force setting for each sprint was 1.1 N·m·kg
Ϫ1
. Peak power, mean power, and total work for each sprint were computed. Peak power was defined as the highest mechanical power output elicited during each sprint. Mean power was defined as the average mechanical power during each 15-second sprint. The rate of fatigue was determined by the decline in total work over the 3 sprints by calculating the individual linear slope (␤) for each subject through a regression analysis.
Creatine Supplementation
Following T1, subjects were provided a total of 6 doses (1 for each day) of either creatine monohydrate or placebo. Both formulations were supplied using the Actijube system (Vitalstate US, Inc., Boynton Beach, FL). The Actijube system is a delivery method using a gel matrix consisting of 3 g creatine monohydrate and a combination of dipotassium phosphate, gelatin, glycerol, high-fructose corn syrup, modified corn starch, pectin potassium citrate, potassium hydroxide, propylene glycol, sucralose, and water. The placebo was formulated to deliver on a per dose basis the same amount of all ingredients except creatine and was indistinguishable in appearance and taste from the creatine Actijube. The creatine component in the placebo was replaced by cellulose powder and methyl cellulose. During each dosing, subjects consumed 2 Actijubes in a single serving. Compliance during the 6 days of supplementation was 100%.
On T1, subjects were asked to arrive at the laboratory at least 2 hours postprandial. The initial dose was provided within 15 minutes of the conclusion of the testing session and was witnessed by one of the investigators. The subjects were then instructed to take the next 5 doses with 240 ml of water on an empty stomach every morning before breakfast. The subjects were asked to record the time they took the supplement. There was no dose required on the morning of T2.
Statistical Analyses
Statistical evaluation of the data was accomplished by a 2-way (group ϫ time) analysis of variance (ANOVA). In the event of a significant F ratio, Tukey post hoc tests were employed. A 2-way ANOVA was used to analyze the area under curve, which was calculated by using a standard trapezoidal technique. In addition, ⌬ peak power, mean power, total work, and rate of fatigue (defined as mean performance results of each sprint of T1 Ϫ mean performance results of each sprint of T2) were analyzed with independent t-tests. Significance for all statistical analyses was set at p Յ 0.05. A sample size of 40 subjects provided more than 85% statistical power at an ␣ level of 0.05 (2-tailed).
RESULTS
During the 6-day study period, no significant changes in body mass were seen from before to after in either the P (83.3 Ϯ 10.6 kg to 83.3 Ϯ 10.5 kg, respectively) or Cr (83.9 Ϯ 8.7 kg to 83.9 Ϯ 8.9 kg, respectively) group. In addition, no adverse side effects were reported from subjects in either group. The effects of creatine supplementation on peak power, mean power, and total work for each sprint can be seen in Table 1 . No significant group or time effects were observed. Area under curve analysis also revealed no significant between-group differences. In addition, no significant differences between the groups were seen in ⌬ peak power, mean power, and total work (Figures 1, 2, and 3, respectively) . However, the change in the rate of fatigue of total work was significantly lower (indicated by an elevated ⌬ ␤ values) in Cr than in P, indicating a reduced fatigue rate in subjects supplementing with creatine compared to placebo (see Figure 4) .
DISCUSSION
Results of this study demonstrate that short-duration, low-dose creatine supplementation does not provide the same benefits (i.e., improved power performance) generally seen in longer-duration dosing studies. However, results do indicate that short-duration, low-dose creatine use may provide a potential benefit in delaying the rate of fatigue during short-duration interval sprints. Previous studies that have showed benefits of short-term (5-6 days) creatine supplementation have used similar performance protocols (e.g., repetitive or long sprints) as those used in this present study. But in contrast to this study, the other researchers used a typical loading phase (20 g·d Ϫ1 ) (4, 5, 8, 17, 20, 24) . The basic premise behind the use of a 5-to 6-day loading phase is to maximize muscle creatine concentrations in a short period of time (12) . Still, other studies using a similar loading-phase dosing regimen and supplement duration were unable to see any significant performance improvements (6, 7, 16, 25) . This was likely related to the performance variable evaluated. In those studies that reported significant performance improvements during short-duration creatine supplementation, repetitive or long sprints were generally used, FIGURE 1 . Effect of creatine supplementation on ⌬ peak power. All data are presented as mean Ϯ SD. Cr ϭ creatine group; P ϭ placebo group; w ϭ watts.
FIGURE 2.
Effect of creatine supplementation on ⌬ mean power. All data are presented as mean Ϯ SD. Cr ϭ creatine group; P ϭ placebo group; w ϭ watts.
FIGURE 3.
Effect of creatine supplementation on ⌬ total work. All data are presented as mean Ϯ SD. Cr ϭ creatine group; P ϭ placebo group; J ϭ joules.
whereas studies that failed to see any performance improvement typically used a single, short-duration highintensity performance test. One of the physiological roles of creatine is increasing the rephosphorylation of adenosine diphosphate through the creatine kinase reaction (22) . The benefit of increasing creatine stores is primarily in reducing neuromuscular fatigue by decreasing reliance on anaerobic glycolysis and delaying lactate accumulation during high-intensity exercise. Thus, in studies examining a single short-duration sprint or in power performance (i.e., those in which fatigue may not be an issue), the physiological benefit of higher muscle creatine stores would not be realized. However, in performance measures that require repetitive high-intensity activity, the ability to rapidly rephosphor-FIGURE 4. Effect of creatine supplementation on rate of fatigue of total work. All data are presented as mean Ϯ SD. * ϭ significant difference between P and Cr. Cr ϭ creatine group; P ϭ placebo group; ␤ ϭ linear slope.
ylate adenosine diphosphate would likely reduce the rate of fatigue. The results of this study support the hypothesis that higher muscle creatine concentrations provide fatigue resistance during repetitive, high-intensity exercise.
An interesting aspect of this study was the finding that a short-duration, low-dose supplement regimen was able to elicit similar improvements in fatigue rates to those that have generally been seen only in studies employing a loading phase. Only one study has used a similar supplement dosage (7.7 g·d
Ϫ1
) and reported significant performance improvements (3). However, in that study, a 28-day supplement regimen was used. As such, it is likely that muscle creatine concentrations in those subjects were at or near maximal levels. Hultman et al. (12) showed that a fivefold difference in supplement duration was needed to achieve maximal muscle creatine concentrations when comparing 3 g·d Ϫ1 to 20 g·d Ϫ1 . It is unlikely that a 6 g·d Ϫ1 supplementation regimen would require 30 days to achieve similar creatine concentrations. Harris and colleagues (11) have shown that creatine uptake into muscle is greatest during the first 2 days of loading. However, they used a typical loading dose, and not the low-dose regimen used in this study. Although no studies are known that have examined creatine uptake into skeletal muscle, using a dosing scheme employed in this study, it is likely that muscle creatine concentrations would still be elevated using such a dosing regimen. However, as muscle creatine concentrations were not measured here, discussion can only be speculative.
The need for maximizing muscle creatine concentrations is also unclear. Previous research has suggested that creatine supplementation elevates muscle creatine stores by 20% (11) . The majority of muscle creatine uptake also appears to occur during the initial 2 days of supplementation, with a lower retention of the administered dose during subsequent supplementation days (12) . How creatine retention rates differ in lower-dose administrations is unknown, but a more important question might be whether maximal creatine levels need to be achieved for significant performance effects to occur. Although the results of our study do not address this question, they do indicate that elevating muscle creatine concentrations (albeit not maximally) leads to performance enhancement.
An interesting aspect of this study is the delivery system used. Unpublished clinical trials indicate that the gel matrix used in the Actijube formulation may have significantly greater absorption ability from the intestines when compared to the basic powder formulation used in most other creatine supplements (28) . If a greater quantity of creatine is absorbed, there is a greater likelihood of increased retention by skeletal muscle. However, further research is warranted concerning creatine absorption rates in skeletal muscle using the Actijube system.
PRACTICAL APPLICATIONS
Performance benefits (i.e., improved power performance) that are typically seen with creatine supplementation were not demonstrated in this study. However, the results of this study did show that low-dose, short-duration creatine supplementation reduced fatigue rates in physically active college-aged men. Although speculative, it is possible that changes in fatigue rate may be the initial performance benefit during creatine supplementation that is seen before strength and power improvements. The gel matrix delivery system used in this study requires further examination to determine its potential for quicker absorption than the powder formulation used in other creatine supplementations.
